Billy Abrams
Senior Vice President, Business Development
Aptar CSP Technologies
Billy has worked at Aptar CSP Technologies for 23 years. He started in Operations, transitioned to Project Management and has been responsible for Business Development for over 15 years. Billy has a BA in Economics from Cornell University and a MBA from the Johnson School of Management at Cornell. He has worked on probiotic packaging initiatives for over 15 years and has commercialized countless projects utilizing CSP’s Activ-Polymer ™ technology across a range of application fields with major global pharmaceutical, diagnostic and nutritional supplement companies.
Dr. Gregory Leyer
Chief Scientific Officer
UAS Labs
Greg has dedicated his professional career to probiotic advancement making him not only a critical component of UAS Labs but a world-renowned expert, educator and speaker in the field. To continue driving the industry and UAS Labs forward, Greg continues research in the areas of probiotic bioprocess development, application development, and clinical sciences. To-date he has authored or co-authored 24 publications in the areas of probiotic clinical results, application know-how, safety parameters, and holds patents in the field. In addition, he is an active member of both the International Probiotic Association (IPA) and International Scientific Association for Probiotics and Prebiotics (ISAPP). A graduate of the University of Wisconsin-Madison, Greg received his MS and PhD in Food Microbiology and Toxicology studying the pathogenesis of various organisms including Clostridium botulinum and Salmonella typhimurium. His post-graduate career has since focused on the beneficial effects microbes have on humans.